Product NDC: | 0023-9350 |
Proprietary Name: | SANCTURA |
Non Proprietary Name: | trospium chloride |
Active Ingredient(s): | 60 mg/1 & nbsp; trospium chloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0023-9350 |
Labeler Name: | Allergan, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022103 |
Marketing Category: | NDA |
Start Marketing Date: | 20071201 |
Package NDC: | 0023-9350-30 |
Package Description: | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0023-9350-30) |
NDC Code | 0023-9350-30 |
Proprietary Name | SANCTURA |
Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0023-9350-30) |
Product NDC | 0023-9350 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | trospium chloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20071201 |
Marketing Category Name | NDA |
Labeler Name | Allergan, Inc. |
Substance Name | TROSPIUM CHLORIDE |
Strength Number | 60 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |